In the latest trading session,, 1.03 million Precision Biosciences Inc (NASDAQ:DTIL) shares changed hands as the company’s beta touched 1.52. With the company’s most recent per share price at $4.71 changed hands at -$0.15 or -3.09% at last look, the market valuation stands at $52.23M. DTIL’s current price is a discount, trading about -135.46% off its 52-week high of $11.09. The share price had its 52-week low at $3.61, which suggests the last value was 23.35% up since then. When we look at Precision Biosciences Inc’s average trading volume, we note the 10-day average is 0.21 million shares, with the 3-month average coming to 254.59K.
Analysts gave the Precision Biosciences Inc (DTIL) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 3 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended DTIL as a Hold, 3 felt it is a Buy and 0 rated the stock as Underweight.
Precision Biosciences Inc (NASDAQ:DTIL) trade information
Instantly DTIL was in red as seen in intraday trades today. With action 4.20%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -52.33%, with the 5-day performance at 4.20% in the green. However, in the 30-day time frame, Precision Biosciences Inc (NASDAQ:DTIL) is 3.97% up. Looking at the short shares, we see there were 1.3 million shares sold at short interest cover period of 2.56 days.
The consensus price target for the stock as assigned by Wall Street analysts is 15.5, meaning bulls need an upside of 69.61% from its recent market value. According to analyst projections, DTIL’s forecast low is 1 with 30 as the target high. To hit the forecast high, the stock’s price needs a -536.94% plunge from its current level, while the stock would need to tank 78.77% for it to hit the projected low.
The 2025 estimates are for Precision Biosciences Inc earnings to decrease by -749.36%.
DTIL Dividends
Precision Biosciences Inc is expected to release its next quarterly earnings report on 2025-Jun-04.
Precision Biosciences Inc (NASDAQ:DTIL)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 10.94% of Precision Biosciences Inc shares while 42.73% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 47.98%. There are 42.73% institutions holding the Precision Biosciences Inc stock share, with JANUS HENDERSON GROUP PLC the top institutional holder. As of 2024-06-30, the company held 9.0879% of the shares, roughly 0.63 million DTIL shares worth $6.18 million.
TANG CAPITAL MANAGEMENT LLC holds the second largest percentage of outstanding shares, with 8.9473% or 0.62 million shares worth $6.07 million as of 2024-06-30.
Among Mutual Funds, the top two as of Mar 31, 2025 were VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund . With 174.93 shares estimated at $0.85 million under it, the former controlled 1.58% of total outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund held about 0.67% of the shares, roughly 74.66 shares worth around $0.36 million.
